The biotechnology company Linkgevity from the United Kingdom has announced a breakthrough in the field of slowing age -related processes. Its scientists, according to Dr. Karin Kern CEO, have developed new experimental drugs that can not only fight age diseases, but also influence the aging process.
We are talking about miracle pills, which, according to preliminary data, are able to influence the key mechanism of cellular death-necrosis.
What is necrosis and why it is important
Necrosis is a form of cell death, which, unlike apoptosis (programmed cell death), is chaotic, causes inflammation and is often accompanied by damage to the surrounding tissues. In recent years, the scientific community has begun to study its role more deeply in the development of age -related diseases.
The key factor, as Dr. Kern explains, is calcium. Normally, its concentration inside the cell is very low, but during stress, calcium levels increase sharply, disrupting cellular equilibrium and triggering necrosis.
"We have long underestimated the value of necrosis," Kern notes. "It is now clear that it is not only a symptom of aging, but also one of its main starting mechanisms."
What exactly offers LinkGevity
The drugs developed by the company are aimed at stopping or significantly slowing down necrosis, protecting cells from the destructive effect of excess calcium. This opens the ability to maintain the health of tissues and organs even in the elderly.
The research is still in the preclinical stage, but clinical trials are planning to start this year.
Prospects for medicine
Successful test results can open a new era in gerontology and pharmacology. If it is proven that new drugs effectively reduce cell damage with age, it will create a new generation of drugs against diseases such as Alzheimer's disease, heart failure or age -related muscle atrophy.
Despite the fact that it is too early to talk about the rapid entry into the market, the very fact of active study of necrosis as a cause of aging is already an important step in the future of medicine.
